Nasal Polyps
Showing 26 - 50 of 6,757
Chronic Rhinosinusitis With Nasal Polyps Trial (CM326, Placebo)
Not yet recruiting
- Chronic Rhinosinusitis With Nasal Polyps
- CM326
- Placebo
- (no location specified)
Jul 19, 2022
Chronic Sinusitis, Endoscopic Sinus Surgery, Nasal Polyps Trial in Wuhan (Modified radical endoscopic sinus surgery, functional
Recruiting
- Chronic Sinusitis
- +2 more
- Modified radical endoscopic sinus surgery
- functional endoscopic sinus surgery
-
Wuhan, Hubei, ChinaDepartment of ENT, Tongji Hospital, Tongji Medical College, Huaz
Aug 2, 2022
Chronic Sinusitis Trial in Baltimore (dupilumab, )
Recruiting
- Chronic Sinusitis
- dupilumab
- placebo
-
Baltimore, MarylandJohns Hopkins University School of Medicine
Oct 12, 2022
Endoscopic Frontal Sinus Surgery, Chronic Rhinosinusitis With Nasal Polyps, Draf III Trial in Tanta (Endoscopic frontal sinus
Recruiting
- Endoscopic Frontal Sinus Surgery
- +3 more
- Endoscopic frontal sinus surgery grade 6(Draf III).
- Endoscopic frontal sinus surgery grade 1-3(Draf I or IIa)
-
Tanta, El-Gharbia, Egypt
- +1 more
Jul 29, 2023
Chronic Sinusitis, Nasal Polyps Trial in China (TQC2731 injection, TQC2731 matching )
Not yet recruiting
- Chronic Sinusitis
- Nasal Polyps
- TQC2731 injection
- TQC2731 matching placebo
-
Wuhu, Anhui, China
- +15 more
Sep 12, 2023
Nasal Polyps, Chronic Sinusitis Trial (Thymoquinone (0.5%) and Olive oil ointment)
Not yet recruiting
- Nasal Polyps
- Chronic Sinusitis
- Thymoquinone (0.5%) and Olive oil ointment
- (no location specified)
Oct 1, 2023
Dupilumab in Severe and Recurrent Nasosinusal Polyposis Despite
Not yet recruiting
- Chronic Rhinosinusitis With Nasal Polyps
- Questionnaires
-
Strasbourg, FranceHautepierre Hospital
Aug 29, 2023
Chronic Rhinosinusitis With Nasal Polyps Trial in Ghent (Mepolizumab)
Recruiting
- Chronic Rhinosinusitis With Nasal Polyps
- Mepolizumab
-
Ghent, BelgiumGhent University Hospital
Jul 6, 2023
CRS, Polyp, Nasal Trial in Kafrelsheikh (Budesonide intrapolyp injection, Budesonide nasal wash, Prednisolone tablets)
Recruiting
- CRS
- Polyp, Nasal
- Budesonide intrapolyp injection
- +2 more
-
Kafrelsheikh, EgyptKafrelsheikh University hospital
Jul 24, 2022
Chronic Rhinosinusitis Without Nasal Polyps, Asthma, Chronic Rhinosinusitis With Nasal Polyps Trial in Copenhagen (Controlgroup,
Not yet recruiting
- Chronic Rhinosinusitis Without Nasal Polyps
- +3 more
- Controlgroup
- Intervention
-
Copenhagen, DenmarkDepartment of Otorhinolaryngology, Head and Neck Surgery & Audio
Sep 21, 2022
Mepolizumab Treatment in Nasal Polyps With or Without Bronchial
Not yet recruiting
- Chronic Rhinosinusitis With Nasal Polyps
- Asthma
- Mepolizumab 100 MG [Nucala]
-
Thessaloniki, Exochi, GreecePulmonary Clinic of Aristotle University of Thessaloniki, George
Jan 23, 2023
Nasal Polyps Trial in Shiraz (Omalizumab, SNOT22 score)
Not yet recruiting
- Nasal Polyps
- Omalizumab
- SNOT22 score
-
Shiraz, Fars, Iran, Islamic Republic ofImam Reza Allergy and Immunology clinic, Shiraz University of Me
May 31, 2022
IL-5R Signaling in Non-eosinophil Upper Airway Cells in CRSwNP
Recruiting
- Nasal Polyps
- Aspirin-exacerbated Respiratory Disease
- Non-Interventional
-
Boston, MassachusettsBrigham and Women's Hospital
Jan 5, 2023
Sinusitis, Nasal Polyps Trial in Canada (Endoscopic polypectomy in clinic (EPIC), Endoscopic Sinus Surgery (ESS), General
Recruiting
- Sinusitis
- Nasal Polyps
- Endoscopic polypectomy in clinic (EPIC)
- +3 more
-
Vancouver, British Columbia, Canada
- +3 more
Sep 20, 2022
Chronic Rhinosinusitis With Nasal Polyps, Olfactory Disorder Trial in London (Dupilumab 300 MG/2 ML Subcutaneous Solution
Recruiting
- Chronic Rhinosinusitis With Nasal Polyps
- Olfactory Disorder
- Dupilumab 300 MG/2 ML Subcutaneous Solution [DUPIXENT]
-
London, Ontario, CanadaSt. Joseph's Health Care
Aug 21, 2022
Nasal Polyps Trial in Philadelphia (Furosemide, Placebo)
Completed
- Nasal Polyps
- Furosemide
- Placebo
-
Philadelphia, PennsylvaniaThomas Jefferson University Department of Otolaryngology
Oct 25, 2022
Chronic Rhinosinusitis With Nasal Polyps, Asthma; Eosinophilic, Eosinophilia Trial in Denmark (dupilumab, mepolizumab)
Recruiting
- Chronic Rhinosinusitis With Nasal Polyps
- +2 more
- dupilumab
- mepolizumab
-
Aalborg, Denmark
- +8 more
Jul 3, 2023
Retrospective Study for Recurrent Nasal Polyposis
Completed
- Nasal Polyps
- nasal polyp surgery
-
Sohag, EgyptSohag University hospital
Jul 3, 2022
Montelukast, Chronic Rhinosinusitis With Nasal Polyps Trial in Assiut (Montelukast, Prednisolone, Fluticasone Furoate)
Active, not recruiting
- Montelukast
- Chronic Rhinosinusitis With Nasal Polyps
- Montelukast
- +2 more
-
Assiut, EgyptAssiut University Hospital
Mar 6, 2022
Nasal Polyps, Asthma, Aspirin-Induced, Aspirin-exacerbated Respiratory Disease Trial in Boston (Ifetroban, Placebo)
Active, not recruiting
- Nasal Polyps
- +3 more
- Ifetroban
- Placebo
-
Boston, MassachusettsAsthma Research Center, Brigham and Women's Hospital
Oct 7, 2022
Nasal Polyps, Chronic Rhinosinusitis With Nasal Polyps Trial (Doxycycline 100 mg Oral Tablet, Prednisolone 20 mg)
Not yet recruiting
- Nasal Polyps
- Chronic Rhinosinusitis With Nasal Polyps
- Doxycycline 100 mg Oral Tablet
- Prednisolone 20 mg
- (no location specified)
Jan 24, 2022
Asthma, Aspirin-Induced, Chronic Rhinosinusitis With Nasal Polyps Trial in Helsinki (Mepolizumab, Placebo)
Recruiting
- Asthma, Aspirin-Induced
- Chronic Rhinosinusitis With Nasal Polyps
- Mepolizumab
- Placebo
-
Helsinki, FinlandHelsinki University Hospital
Aug 5, 2022
Nasal Polyps Trial (Mometasone Furoate Nasal Spray (MFNS), Placebo for MFNS)
Completed
- Nasal Polyps
- Mometasone Furoate Nasal Spray (MFNS)
- Placebo for MFNS
- (no location specified)
Feb 7, 2022
Nasal Polyps Trial (Mometasone Furoate Nasal Spray (MFNS), Placebo nasal spray)
Completed
- Nasal Polyps
- Mometasone Furoate Nasal Spray (MFNS)
- Placebo nasal spray
- (no location specified)
Feb 7, 2022
BIOlogics in Severe Nasal POlyposis SurvEy
Recruiting
- Chronic Rhinosinusitis With Nasal Polyps
- Biologic treatments available in CRSwNP (dupilumab, mepolizumab and benralizumab according to their marketing approval)
-
Lille, FranceHop Claude Huriez Chu Lille
Apr 4, 2022